Updated:
Tactile Systems Technology Inc.
Tactile Systems Technology Inc. (TCMD) is a publicly traded Minneapolis-based firm developing pneumatic compression devices for lymphedema and venous...
Tactile Systems Technology Inc.
Tactile Systems Technology Inc. was founded in 1995 and is publicly traded under ticker TCMD on the Nasdaq. The company is led by CEO Sherri Ferstler, who took the role in 2020, and it focuses exclusively on advanced pneumatic compression devices for chronic venous and lymphatic disorders. Wealth origin is corporate — the firm generates revenue through device sales and rentals, not family capital. The company's primary product lines are the Flexitouch and Entre systems, which are FDA-cleared for at-home use by patients with lymphedema and venous leg ulcers. Tactile has invested in clinical studies to support reimbursement from Medicare and private insurers, a key strategic moat. The firm's go-to-market relies on a direct sales force targeting vascular and wound care specialists. Geographically, Tactile operates mainly in the United States, with some international expansion per SEC filings. As of 2025, Tactile employs approximately 600 people and reported annual revenue near $250M per public filings. The firm maintains its headquarters in Minneapolis with additional offices for manufacturing and distribution. No adjacent philanthropic or operating-company vehicles have been disclosed beyond the corporate structure. In Q3 2025, Tactile launched the Entre+ system, a next-generation device with Bluetooth connectivity for remote patient monitoring (per SEC filing, August 2025). A structural differentiator is Tactile's reliance on durable medical equipment (DME) reimbursement pathways rather than physician-administered procedures. This model creates a subscription-like revenue stream from device rentals and supplies, insulating the firm from variability in surgical volumes. The company's intellectual property portfolio — over 100 patents — further distinguishes it within the med-tech space.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Minneapolis
Corporate office
Minneapolis, MN, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Tactile Systems Technology Inc.?
As a publicly traded company, capital allocation is managed by the executive team led by CEO Sherri Ferstler and the board of directors. Tactile does not operate as a family office or asset manager, so investment decisions are corporate — focused on R&D, sales force expansion, and potential acquisitions. The company's SEC filings detail these allocations.
How does Tactile Systems Technology generate its revenue?
Tactile generates revenue primarily through the sale and rental of its pneumatic compression devices, such as Flexitouch and Entre systems, along with associated supplies and service. Reimbursement from Medicare and private insurers for home-use lymphedema treatment drives the bulk of revenue. The company reports this in its annual 10-K filings.
Is Tactile Systems Technology related to any family office or venture firm?
No. Tactile Systems Technology Inc. is a publicly traded medical device company with no disclosed affiliation with any family office. Its primary investors are institutional shareholders and public market participants. The firm's structure is corporate, not fiduciary.
What investment stages does Tactile Systems Technology typically target?
Tactile does not operate as an investment firm. Its capital deployment is corporate — internal R&D, commercial expansion, and manufacturing. As a public company, it does not target investment stages in the venture or private equity sense.
Which sectors does Tactile Systems Technology explicitly avoid?
Tactile explicitly focuses on the medical device subsector of compression therapy for chronic vascular and lymphatic conditions. It does not engage in pharmaceuticals, diagnostics, or other med-tech verticals like cardiac or orthopedic devices. This focus is evident from its product portfolio and SEC disclosures.
How is Tactile Systems Technology related to the parent company or other entities?
Tactile Systems Technology Inc. is an independent publicly traded company with no parent entity. It has no disclosed spinout or subsidiary relationships beyond standard operating subsidiaries listed in SEC filings. There is no family-office or conglomerate ownership.
Does Tactile Systems Technology maintain philanthropic structures?
Tactile Systems Technology has not publicly disclosed a separate charitable foundation. The company has supported patient advocacy groups for lymphedema awareness through corporate partnerships, but these are not formal philanthropic vehicles. No separate 501(c)(3) entity has been identified in public records.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: